Titre du document / Document title
Detecting and treating retinopathy in patients with type I diabetes mellitus : savings associated with improved implementation of current guidelines. Discussion
Auteur(s) / Author(s)
JAVITT J. C.
(1) ;
AIELLO L. P. ;
BASSI L. J. ;
CHIANG E. P. ;
CANNER J. K. ;
KLEIN R. (Commentateur)
;
FRYBACK D. G. ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
(1) Georgetown univ. medical cent., cent. sight, worthen cent. eye care res., Washington PA, ETATS-UNIS
Résumé / Abstract
Diabetic retinopathy is the leading cause of acquired blindness among Americans of working age. The resulting economic and societal burdens are of profound magnitude. Epidemiologic and clinical trials data were used to analyze the impact of improved recruitment of patients with Type I diabetes mellitus into screening and treatment programs. The analysis predicted annual savings of $101.0 million and 47,374 person-years-sight at the currently estimated 60% screening and treatment implementation level. If all patients receive appropriate eye care, the predicted savings exceed 167.0 million and 79,236 person-years-sight
Revue / Journal Title
Ophthalmology
ISSN 0161-6420
CODEN OPHTDG
Source / Source
Congrès
American academy ophthalmology . Annual meeting, Atlanta GA
, ETATS-UNIS
(10/1990)
1991, vol. 98, n
o10, pp. 1565-1574 (49 ref.)
Langue / Language
Anglais
Editeur / Publisher
Elsevier, New York, NY, ETATS-UNIS
(1976)
(Revue)
Mots-clés anglais / English Keywords
Diabetes mellitus ;
Complication ;
Retinopathy ;
Medical screening ;
Treatment ;
Costs ;
Sanitary program ;
Public health ;
Human ;
United States ;
Eye disease ;
Endocrinopathy ;
North America ;
America ;
Mots-clés français / French Keywords
Diabète ;
Complication ;
Rétinopathie ;
Dépistage ;
Traitement ;
Coût ;
Programme sanitaire ;
Santé publique ;
Homme ;
Etats Unis ;
Oeil pathologie ;
Endocrinopathie ;
Amérique du Nord ;
Amérique ;
Mots-clés espagnols / Spanish Keywords
Diabetes ;
Complicación ;
Retinopatía ;
Descubrimiento ;
Tratamiento ;
Costo ;
Programa sanitario ;
Salud pública ;
Hombre ;
Estados Unidos ;
Ojo patología ;
Endocrinopatía ;
America del norte ;
America ;
Localisation / Location
INIST-CNRS, Cote INIST : 18914, 35400001132167.0200
Nº notice refdoc (ud4) : 4433425
